# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2451-2460 of 2745 results.
A Safety Study of SGN-CD47M in Patients With Solid Tumors
Status: Terminated
Last Changed: Sep 17, 2020
First Received: May 21, 2019
Disease(s): Soft Tissue Sarcoma, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Non-small Cell Lung Carcinoma, Breast Carcinoma, Ovarian Carcinoma, Exocrine Pancreatic Carcinoma, Gastric Carcinoma, Melanoma
Intervention(s): SGN-CD47M
Locations: Case Western Reserve University / University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Providence Portland Medical Center, Portland, Oregon, United States
Tennessee Oncology-Nashvilee/Sarah Cannon Research Institute, Nashville, Tennessee, United States
MD Anderson Cancer Center / University of Texas, Houston, Texas, United States
NEXT Oncology, San Antonio, Texas, United States
... and 1 other locations.
Pharmacokinetic Study of PM01183 in Combination With Irinotecan in Patients With Selected Solid Tumors
Status: Recruiting
Last Changed: Jun 09, 2020
First Received: Nov 20, 2015
Disease(s): Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma, Endometrial Carcinoma, Ovarian Carcinoma, Mesothelioma, Gastroenteropancreatic Neuroendocrine Tumor, SCLC, Gastric Carcinoma
Intervention(s): lurbinectedin (PM01183), Irinotecan
Locations: Massachusetts General Hospital -, Boston, Massachusetts, United States
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Virgen Del Rocio, Sevilla, Spain
Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology
Status: Completed
Last Changed: Jun 14, 2017
First Received: Jun 14, 2017
Disease(s): Salpingectomy, Hysterectomy
Locations: Hôpital Femme Mère Enfant, Bron, France
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
Status: Active, not recruiting
Last Changed: Oct 30, 2020
First Received: Jul 18, 2014
Disease(s): Body Mass Index 25 or Greater, BRCA1 Gene Mutation, BRCA2 Gene Mutation, Breast Carcinoma, Cancer Survivor, Chronic Lymphocytic Leukemia, Fatigue, Health Status Unknown, Lynch Syndrome, Ovarian Carcinoma, Overweight
Intervention(s): Dietary Intervention, Dietary Intervention, Internet-Based Intervention, Internet-Based Intervention, Laboratory Biomarker Analysis, Questionnaire Administration, Telephone-Based Intervention, Telephone-Based Intervention
Locations: M D Anderson Cancer Center, Houston, Texas, United States
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Status: Active, not recruiting
Last Changed: May 28, 2020
First Received: Jun 03, 2011
Disease(s): Breast Carcinoma, Carcinoma of Unknown Primary, Endometrial Carcinoma, Esophageal Carcinoma, Liver Failure, Lung Carcinoma, Malignant Head and Neck Neoplasm, Malignant Testicular Neoplasm, Melanoma, Metastatic Malignant Neoplasm, Ovarian Carcinoma, Renal Failure, Unresectable Malignant Neoplasm, Urothelial Carcinoma
Intervention(s): Carboplatin, Laboratory Biomarker Analysis, Paclitaxel, Pharmacological Study, Veliparib
Locations: City of Hope Comprehensive Cancer Center, Duarte, California, United States
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
City of Hope South Pasadena, South Pasadena, California, United States
Moffitt Cancer Center, Tampa, Florida, United States
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
... and 13 other locations.
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Status: Completed
Last Changed: Jan 09, 2017
First Received: Feb 26, 2008
Disease(s): Melanoma, Sarcoma, Gastrointestinal Stromal Tumor (GIST), Head and Neck Cancer, Transitional Cell Carcinoma, Prostate Cancer, Ovarian Carcinoma, Esophageal Cancer, Breast Cancer
Intervention(s): Mixed bacterial vaccine
Locations: Krankenhaus Nordwest, Frankfurt, Germany
PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis
Status: Not yet recruiting
Last Changed: Jul 29, 2020
First Received: Jun 27, 2019
Disease(s): Peritoneal Carcinomatosis
Intervention(s): Nab paclitaxel, Cisplatin
Locations: University Hospital, Lausanne, Lausanne, Vaud, Switzerland
University Hospital, Geneva, Geneva, Switzerland
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Status: Recruiting
Last Changed: Mar 13, 2019
First Received: Jul 26, 2018
Disease(s): HER2-positive Breast Cancer, HER2 Gene Mutation, HER-2 Gene Amplification, HER2 Positive Gastric Cancer, Salivary Gland Cancer, Salivary Gland Tumor, Salivary Gland Carcinoma, Salivary Gland Neoplasms, Lung Cancer, Colo-rectal Cancer, Rare Diseases, Solid Tumor, Recurrent Gastric Cancer, Recurrent Colon Cancer, Recurrent Breast Cancer, Head and Neck Cancer, Head and Neck Carcinoma, Bladder Cancer, Cervical Cancer, Liver Cancer, Bile Duct Cancer, Urologic Cancer, Pancreatic Cancer, Prostate Cancer, Recurrent Prostate Cancer, Rectal Cancer, Recurrent Ovarian Carcinoma, Recurrent Renal Cell Cancer, Rectal Cancer Stage II, Rectal Cancer Stage I, Rectal Cancer Stage III, Skin Cancer, Mouth Cancer, Lip Cancer Stage I, Tongue Cancer, Breast Neoplasm Malignant Primary, Larynx Cancer, Tonsil Cancer, Palate Cancer, Mucoepidermoid Carcinoma, Primary Peritoneal Carcinoma, Mucinous Adenocarcinoma Gastric, Mucinous Breast Cancer Recurrent, Cholangiocarcinoma
Intervention(s): A166
Locations: Florida Cancer Specialists & Research Institute, Sarasota, Florida, United States
Beth Israel Deaconess Medical Center Cancer Center, Boston, Massachusetts, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Clinical Research Alliance, Inc., Lake Success, New York, United States
Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
... and 6 other locations.
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
Status: Recruiting
Last Changed: Jan 18, 2020
First Received: Dec 13, 2016
Disease(s): Cancer, Breast, Cancer, Colorectal, Cancer, Lung, Cancer, Ovarian
Intervention(s): aerobic exercise intervention, control group, resistive training
Locations: Baltimore VA Medical Center, Baltimore, Maryland, United States
To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers
Status: Completed
Last Changed: Jul 23, 2019
First Received: Jul 02, 2014
Disease(s): Pancreatic Adenocarcinoma Metastatic, Ovarian Serous Adenocarcinoma, Colorectal Cancer Metastatic
Intervention(s): Plerixafor
Locations: Addenbrookes Hospital, Cambridge, United Kingdom